v3.26.1
Consolidated Statements of Stockholders Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Balance, shares at Dec. 31, 2024   189      
Balance, amount at Dec. 31, 2024 $ 2,857 $ 1 $ 53,194 $ (50,136) $ (202)
Stock based compensation 192 0 192 0 0
Net loss for the period (2,372) 0 0 (2,372) 0
Other comprehensive loss (25) $ 0 0 0 (25)
Balance, shares at Mar. 31, 2025   189      
Balance, amount at Mar. 31, 2025 652 $ 1 53,386 (52,508) (227)
Balance, shares at Dec. 31, 2024   189      
Balance, amount at Dec. 31, 2024 2,857 $ 1 53,194 (50,136) (202)
Other comprehensive loss (93)        
Balance, shares at Jun. 30, 2025   235      
Balance, amount at Jun. 30, 2025 (1,406) $ 1 54,617 (55,729) (295)
Balance, shares at Mar. 31, 2025   189      
Balance, amount at Mar. 31, 2025 652 $ 1 53,386 (52,508) (227)
Stock based compensation 150 0 150 0 0
Net loss for the period (3,221) 0 0 (3,221) 0
Other comprehensive loss (68) $ 0 0 0 (68)
Common shares issued for cash, net of issuance costs, shares   46      
Common shares issued for cash, net of issuance costs, amount 1,081 $ 0 1,081 0 0
Balance, shares at Jun. 30, 2025   235      
Balance, amount at Jun. 30, 2025 (1,406) $ 1 54,617 (55,729) (295)
Balance, shares at Dec. 31, 2025   673      
Balance, amount at Dec. 31, 2025 (1,272) $ 1 62,014 (63,015) (272)
Stock based compensation 256 0 256 0 0
Net loss for the period (2,958) 0 0 (2,958) 0
Other comprehensive loss 26 $ 0 0 0 26
Common shares issued for cash, net of issuance costs, shares   81      
Common shares issued for cash, net of issuance costs, amount 10,033 $ 0 10,033 0 0
Reverse split adjustment, shares   28      
Reverse split adjustment, amount 0 $ 0 0 0 0
Common shares issued as a fee in equity purchase agreement, shares   35      
Common shares issued as a fee in equity purchase agreement, amount 145 $ 0 145 0 0
Warrants exercised, shares   39      
Warrants exercised, amount 234 $ 0 234 0 0
Conversion of convertible notes to common stock, shares   20      
Conversion of convertible notes to common stock, amount 208 $ 0 208 0 0
Balance, shares at Mar. 31, 2026   876      
Balance, amount at Mar. 31, 2026 6,672 $ 1 72,890 (65,973) (246)
Balance, shares at Dec. 31, 2025   673      
Balance, amount at Dec. 31, 2025 (1,272) $ 1 62,014 (63,015) (272)
Other comprehensive loss 30        
Balance, shares at Jun. 30, 2026   4,188      
Balance, amount at Jun. 30, 2026 4,997 $ 4 73,635 (68,400) (242)
Balance, shares at Mar. 31, 2026   876      
Balance, amount at Mar. 31, 2026 6,672 $ 1 72,890 (65,973) (246)
Stock based compensation 216 0 216 0 0
Net loss for the period (2,427) 0 0 (2,427) 0
Other comprehensive loss 4 $ 0 0 0 4
Common shares issued for cash, net of issuance costs, shares   143      
Common shares issued for cash, net of issuance costs, amount 174 $ 0 174 0 0
Common shares issued as a fee in equity purchase agreement, shares   62      
Common shares issued as a fee in equity purchase agreement, amount 355 $ 0 355 0 0
Warrants exercised, shares   3,107      
Warrants exercised, amount 3 $ 3 0 0 0
Balance, shares at Jun. 30, 2026   4,188      
Balance, amount at Jun. 30, 2026 $ 4,997 $ 4 $ 73,635 $ (68,400) $ (242)